BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 33104837)

  • 1. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
    Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
    Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
    Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMTM6 and PD-1/PD-L1 overexpression is associated with the clinical characteristics of malignancy in oral squamous cell carcinoma.
    Zhang S; Yan Q; Wei S; Feng X; Xue M; Liu L; Cui J; Zhang Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Aug; 132(2):202-209. PubMed ID: 34034998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress promotes the release of exosomal PD-L1 from head and neck cancer cells and facilitates M2 macrophage polarization.
    Yuan Y; Jiao P; Wang Z; Chen M; Du H; Xu L; Xu J; Dai Y; Wu FG; Zhang Y; Wu H
    Cell Commun Signal; 2022 Jan; 20(1):12. PubMed ID: 35090495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer.
    Wu X; Lan X; Hu W; Zhang W; Lai X; Xu S; Li J; Qiu W; Wang W; Xiao J; Wang F; Ding Y; Liang L
    Cancer Immunol Immunother; 2021 Nov; 70(11):3235-3248. PubMed ID: 33818637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
    Chi J; Liu Y; Yang L; Yang J
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma.
    Xiao M; Zhang J; Chen W; Chen W
    J Exp Clin Cancer Res; 2018 Jul; 37(1):143. PubMed ID: 29986759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression.
    Wang H; Gao J; Zhang R; Li M; Peng Z; Wang H
    Int Immunopharmacol; 2020 Jun; 83():106478. PubMed ID: 32278132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
    Shang X; Li J; Wang H; Li Z; Lin J; Chen D; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106864. PubMed ID: 32866782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived exosomal miR-21a-5p promotes M2 macrophage polarization and reduces macrophage infiltration to attenuate atherosclerosis.
    Ma J; Chen L; Zhu X; Li Q; Hu L; Li H
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1227-1236. PubMed ID: 34350954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC).
    Pramanik KK; Mishra R
    Exp Cell Res; 2022 Feb; 411(1):112984. PubMed ID: 34951997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence.
    Muranushi R; Araki K; Yokobori T; Chingunjav B; Hoshino K; Dolgormaa G; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Harimoto N; Shimoda Y; Sano R; Oyama T; Saeki H; Shirabe K
    Cancer Sci; 2021 Aug; 112(8):3314-3323. PubMed ID: 34080242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
    Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
    Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma.
    Ishihara S; Iwasaki T; Kohashi K; Yamada Y; Toda Y; Ito Y; Susuki Y; Kawaguchi K; Takamatsu D; Kawatoko S; Kiyozawa D; Mori T; Kinoshita I; Yamamoto H; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Nakashima Y; Oda Y
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2003-2011. PubMed ID: 33811537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
    Chen X; Shen H; Liu H; Tan L; Zhang N
    Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.